Recent Finacing
Recent Raise
Finch Therapeutics develops donor-derived and rationally selected microbiome therapies using Human‑First Discovery and ML bioinformatics platform to manufacture oral microbiota capsules, conduct clinical trials, and partner on IBD programs.
